Physician
Family Medicine
Daniel M. Witt
|
|
Give Review
Daniel Witt practices Family Medicine. Daniel Witt is also a published physician. He has 63 paper published. The most recent paper is: Evaluation of excessive anticoagulation in a group model health maintenance organization.
Publications
- Assessment of algorithms to identify patients with thrombophilia following venous thromboembolism.
- Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
- Thromboembolic and bleeding outcomes of extended duration low-intensity warfarin following elective total knee arthroplasty.
- Impact of a clinical pharmacy research team on pharmacy resident research.
- Comment on: Editorial by Husted et al. "Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel". (Thromb Haemost 2014; 111: 781-782).
- An Evaluation of the Potential Drug Interaction between Warfarin and Levothyroxine.
- A descriptive evaluation of warfarin use in patients with pulmonary arterial hypertension.
- Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes.
- Interventions aimed at improving performance on medication adherence metrics.
- Challenges to publishing pharmacy resident research projects from the perspectives of residency program directors and residents.
- Thromboembolic and bleeding outcomes of low-intensity warfarin thromboprophylaxis following elective total hip arthroplasty.
- Evolution, current structure, and role of a primary care clinical pharmacy service in an integrated managed care organization.
- Pilot Study of a Novel Patient Self-Management Program for Warfarin Therapy Using Venipuncture-Acquired International Normalized Ratio Monitoring.
- Approaches to Optimal Dosing of Vitamin K Antagonists.
- ACP Journal Club: rivaroxaban and usual care had similar rates of recurrent VTE and bleeding in symptomatic PE.
- Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Cl...
- Publication rates of abstracts presented by pharmacy residents at the Western States Conference.
- Initiation and reinitiation of anticoagulation therapy.
- Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis.
- Evaluation of venous thromboembolism risk following hospitalization.
- Empiric warfarin dose adjustment with prednisone therapy. A randomized, controlled trial.
- Brand name versus generic warfarin: a systematic review of the literature.
- Quality measures and benchmarking for warfarin therapy.
- ACP Journal Club. Review: Positive D-dimer results predict recurrence after first unprovoked VTE regardless of test timing or cutpoint, or patient age.
- ACP Journal Club. Weekly INR self-testing did not reduce stroke, major bleeding, or death more than monthly clinic testing.
- Optimizing use of current anticoagulants.
- Oral vitamin K effectively treats international normalised ratio (INR) values in excess of 10. Results of a prospective cohort study.
- Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy.
- Twelve-month outcomes and predictors of very stable INR control in prevalent warfarin users.
- Unfractionated heparin dose requirements targeting intermediate intensity antifactor Xa concentration during pregnancy.
- Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary intervention.
- Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy.
- Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention.
- Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study.
- Outcomes and predictors of very stable INR control during chronic anticoagulation therapy.
- A descriptive evaluation of warfarin use in patients receiving hospice or palliative care services.
- A descriptive evaluation of unfractionated heparin use during pregnancy.
- Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.
- The Kaiser Permanente Colorado Clinical Pharmacy Anticoagulation Service as a model of modern anticoagulant care.
- Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
- Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum.
- Outcomes associated with combined antiplatelet and anticoagulant therapy.
- Warfarin and antiplatelet combination use among commercially insured patients enrolled in an anticoagulation management service.
- Falsely elevated international normalized ratio values in patients undergoing anticoagulation therapy: a descriptive evaluation.
- Review: long term anticoagulation reduces recurrent venous thromboembolism.
- Review: Long-term anticoagulation reduces recurrent venous thromboembolism.
- A descriptive evaluation of routine complete blood count monitoring in patients receiving anticoagulation therapy.
- Warfarin monitoring in ambulatory older individuals receiving antimicrobial therapy.
- An examination of the association between therapeutic anticoagulation control and glycemic control for patients with diabetes on oral anticoagulation therapy.
- Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy.
- Impact of evacuated collection tube fill volume and mixing on routine coagulation testing using 2.5-ml (pediatric) tubes.
- A retrospective evaluation of the management of excessive anticoagulation in an established clinical pharmacy anticoagulation service compared to traditional care.
- Evaluation of the clinical and economic impact of a brand name-to-generic warfarin sodium conversion program.
- Effectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organization.
- Randomized, placebo-controlled trial of oral phytonadione for excessive anticoagulation.
- Clinical pharmacy anticoagulation services in a group model health maintenance organization.
- Evaluation of excessive anticoagulation in a group model health maintenance organization.
- Controversies surrounding estrogen use in postmenopausal women.
- Dornase alfa: a new option in the management of cystic fibrosis.
- Amiodarone-clonazepam interaction.
- An Education Program for Patient Self-Management of Warfarin.
- Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol.
Doctors Specialties
- Family Medicine
Accepted Insurances
Helpful Reviews
Similar Doctors
|
Dr. Miriam W. Lindrooth, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pia B. Lisle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip D. Quintana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Greg I. Winter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ann T. Dickson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vishal R. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Edward D. Bordas Jr. |
|
|
Julie M. Corkrean |
|
|
Kara A. Hutka
This Doctor is OpenDoctor Recommended.
|
|
|
Desiree M. Phillips |
|
|
Dawn M. Renouf |
|
|
Stephen L. Rogers, RPH |
|
|
James M. Schirger |
|
|
Yvonne C. Smela, RPH |